Association of type 2 diabetes according to the number of risk factors within the recommended range with incidence of major depression and clinically relevant depressive symptoms: a prospective analysis

Autor: Gennip, A. van, Schram, M.T., Kohler, Sebastian, Kroon, A.A., Koster, A., Eussen, Simone J. P. M., Galan, B.E. de, Sloten, Thomas T. van, Stehouwer, Coen D. A.
Přispěvatelé: Interne Geneeskunde, RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, RS: MHeNs - R1 - Cognitive Neuropsychiatry and Clinical Neuroscience, Psychology 5, MUMC+: MA Alg Interne Geneeskunde (9), RS: Carim - V02 Hypertension and target organ damage, RS: CAPHRI - R4 - Health Inequities and Societal Participation, Sociale Geneeskunde, RS: CAPHRI - R5 - Optimising Patient Care, Epidemiologie, MUMC+: MA Endocrinologie (9), MUMC+: MA Interne Geneeskunde (3)
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: The Lancet Healthy Longevity, 4(2), 63-71. Lancet Publishing Group
The Lancet Healthy Longevity, 4, 63-71
The Lancet Healthy Longevity, 4, 2, pp. 63-71
ISSN: 2666-7568
Popis: Background Type 2 diabetes is associated with an increased risk of depression, but the extent to which risk factor modification can mitigate this risk is unclear. We aimed to examine the association between the incidence of major depression and clinically relevant depressive symptoms among individuals with type 2 diabetes, according to the number of risk factors within the recommended target range, compared with individuals without diabetes.Methods We did a prospective analysis of population-based data from the UK Biobank and the Maastricht Study. Individuals with type 2 diabetes were categorised according to the number of risk factors within the recommended target range (non-smoking, guideline-recommended levels of glycated haemoglobin (HbA1c), blood pressure, BMI, albuminuria, physical activity, and diet). The primary outcome, based on data from the UK Biobank, was the incidence of major depression ascertained from hospital records; the secondary outcome, based on data from the UK Biobank and the Maastricht Study, was clinically relevant depressive symptoms based on a score of 10 or higher on the Patient Health Questionnaire (PHQ-9).Findings The study population of the UK Biobank comprised 77 786 individuals (9047 with type 2 diabetes and 68 739 without diabetes; median age 59 years [IQR 51-64]; 34 136 [43middot9%] women and 43 650 [56middot1%] men). A median of 12middot7 years (IQR 11middot8-13middot4) after recruitment (between March 13, 2006, and Oct 1, 2010), 493 (5middot5%) of 9047 individuals with type 2 diabetes and 2574 (3middot7%) of 68 739 individuals without diabetes developed major depression. Compared with individuals without diabetes, those with type 2 diabetes had a higher risk of major depression (hazard ratio [HR] 1middot61 [95% CI 1middot49-1middot77]). Among individuals with type 2 diabetes, the excess risk of depression decreased stepwise with an increasing number of risk factors within the recommended target range (HR 2middot04 [95% CI 1middot65-2middot52] for up to two risk factors within the recommended target range; 1middot95 [1middot65-2middot30] for three risk factors within the recommended target range; 1middot38 [1middot16-1middot65] for four risk factors within the recommended target range; and 1middot34 [1middot12-1middot62] for five to seven risk factors within the recommended target range). In the UK Biobank dataset, a median of 7middot5 years (IQR 6middot8-8middot2) after the baseline examination, 147 (7middot5%) of 1953 individuals with type 2 diabetes and 954 (4middot5%) of 21 413 individuals without diabetes had developed clinically relevant depressive symptoms. The study population of the Maastricht Study comprised 4530 individuals (1158 with type 2 diabetes and 3372 without diabetes; median age 60 years [IQR 53-66]; 2244 [49middot5%] women and 2286 [50middot1%] men). A median of 5middot1 years (IQR 4middot1-6middot1) after recruitment (between Sept 1, 2010, and Dec 7, 2017), 170 (14middot7%) of 1158 individuals with type 2 diabetes and 227 (6middot7%) of 3372 individuals without diabetes developed clinically relevant depressive symptoms. Similarly, in both the UK Biobank dataset and the Maastricht Study cohort, among individuals with type 2 diabetes, the excess risk of clinically relevant depressive symptoms decreased stepwise with an increasing number of risk factors within the recommended target range.Interpretation Among individuals with type 2 diabetes, the excess risk of major depression and clinically relevant depressive symptoms decreased stepwise with an increasing number of risk factors within the recommended target range. This study provides further evidence to promote risk factor modification strategies in individuals with type 2 diabetes and to encourage the adoption of a healthy lifestyle.Copyright (c) 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Databáze: OpenAIRE
Externí odkaz: